MYND Life Sciences Inc. (MYNDF)
USD 0.01
(-85.19%)
USD 0.01
(-85.19%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 3 Million CAD | 16.0% |
| 2022 | 2.58 Million CAD | 11.32% |
| 2021 | 2.32 Million CAD | 0.0% |
| 2020 | - CAD | 0.0% |
| 2019 | - CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 3 Million CAD | 0.0% |
| 2024 Q3 | 3 Million CAD | 0.0% |
| 2024 Q2 | 3 Million CAD | 0.0% |
| 2023 Q1 | 2.72 Million CAD | 5.42% |
| 2023 FY | 3 Million CAD | 16.0% |
| 2023 Q4 | 3 Million CAD | 1.08% |
| 2023 Q3 | 2.96 Million CAD | 6.38% |
| 2023 Q2 | 2.78 Million CAD | 2.32% |
| 2022 Q1 | 2.42 Million CAD | 4.31% |
| 2022 FY | 2.58 Million CAD | 11.32% |
| 2022 Q4 | 2.58 Million CAD | 4.64% |
| 2022 Q3 | 2.47 Million CAD | 4.96% |
| 2022 Q2 | 2.35 Million CAD | -2.82% |
| 2021 Q1 | 312.01 Thousand CAD | 0.0% |
| 2021 FY | 2.32 Million CAD | 0.0% |
| 2021 Q3 | 336.46 Thousand CAD | -4.23% |
| 2021 Q4 | 2.32 Million CAD | 590.48% |
| 2021 Q2 | 351.32 Thousand CAD | 12.6% |
| 2020 FY | - CAD | 0.0% |
| 2019 FY | - CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Qrons Inc. | 351.84 Thousand USD | -752.643% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | 89.922% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -2348.98% |
| Adynxx, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -11564.528% |
| Capstone Therapeutics Corp. | 20.32 Million USD | 85.242% |
| BioStem Technologies, Inc. | 4.71 Million USD | 36.325% |
| CSL Limited | 12.18 Billion USD | 99.975% |
| Arch Therapeutics, Inc. | 5.87 Million USD | 48.902% |
| Evofem Biosciences, Inc. | 43.37 Million USD | 93.083% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | 93.415% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -296.718% |
| Skye Bioscience, Inc. | 4.61 Million USD | 34.998% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Rebus Holdings, Inc. | 310 Thousand USD | -867.742% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -376.132% |
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | 92.719% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | 27.219% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -646.549% |
| SQZ Biotechnologies Company | 27.47 Million USD | 89.079% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -28.979% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -216.365% |
| Mesoblast Limited | 118.7 Million USD | 97.473% |
| Marizyme, Inc. | 18.71 Million USD | 83.972% |
| Genus plc | 233.1 Million USD | 98.713% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | -2.376% |
| Pharming Group N.V. | 171.54 Million USD | 98.251% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -237.813% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -123.283% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -300.0% |
| ContraFect Corporation | 2.88 Million USD | -4.131% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -2114.235% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -107.423% |
| IMV Inc. | 28.88 Million USD | 89.614% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | 46.981% |
| MultiCell Technologies, Inc. | 202.58 USD | -1480796.436% |
| ONE Bio Corp. | 19.71 Million USD | 84.783% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 57.48 Million USD | 94.782% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 1.49 Million USD | -100.702% |
| Q BioMed Inc. | 4.1 Million USD | 27.007% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | 90.937% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -144.228% |
| Biomind Labs Inc. | 735.54 Thousand USD | -307.863% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | 95.565% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | 0.865% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | 76.918% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -734.005% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -2019.872% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -32.839% |
| GB Sciences, Inc. | 1.75 Million USD | -70.522% |
| Alpha Cognition Inc. | 1.22 Million USD | -145.827% |
| HST Global, Inc. | 98.31 Thousand USD | -2951.292% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -1106.176% |
| Halberd Corporation | 150 Thousand USD | -1900.0% |
| Enzolytics Inc. | 996.33 Thousand USD | -201.103% |
| Agentix Corp. | 50 Thousand USD | -5900.0% |
| Resverlogix Corp. | 6.49 Million USD | 53.782% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -1073.746% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 20 Million USD | 85.0% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 57.584% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -10.754% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -29239.853% |
| Genscript Biotech Corporation | 417.73 Million USD | 99.282% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -1395.394% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -25.119% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -1208.381% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -1918.109% |
| Kadimastem Ltd | 891.22 Thousand USD | -236.615% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -1099.127% |
| LadRx Corporation | 33.6 Thousand USD | -8826.977% |
| Cell Source, Inc. | 9.25 Million USD | 67.582% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -296.718% |
| NovAccess Global Inc. | 2.19 Million USD | -36.371% |
| Affymax, Inc. | - USD | -Infinity% |
| Itoco Inc. | 228.37 Thousand USD | -1213.617% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -1321.969% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | 39.795% |
| Mobile Lads Corp. | 484.28 Thousand USD | -519.471% |
| CytoDyn Inc. | 30.07 Million USD | 90.025% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | 61.637% |
| SYBLEU INC | 477.5 Thousand USD | -528.272% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | 36.646% |
| International Stem Cell Corporation | 4.17 Million USD | 28.195% |
| Bioxytran, Inc. | 1.92 Million USD | -55.844% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -4706.691% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -37.558% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | 63.925% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | 65.055% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -92.867% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -1019.403% |
| Neutra Corp. | 54.15 Thousand USD | -5439.552% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -63.934% |
| PureTech Health plc | 25.51 Million USD | 88.241% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -145.053% |
| IXICO plc | 472.02 Thousand USD | -535.562% |
| IntelGenx Technologies Corp. | 15.5 Million USD | 80.646% |
| Gelesis Holdings, Inc. | 62.26 Million USD | 95.182% |
| CSL Limited | 12.18 Billion USD | 99.975% |
| Cellectis S.A. | 92.77 Million USD | 96.766% |